Addressing social issues in healthcare through robotics and digital technology
First written in FY2022-Q1. 4 of 9 entries say "Advanced", first in FY2023. Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025AdvancedAnnual report
「In January 2025, the company entered into a capital and business alliance agreement with アセントロボティクス株式会社, which develops and sells digital twins, solutions using digital twins and software for industrial robotics.」
Collaboration with venture companies to address social issues in healthcare expanded into a capital and business alliance aimed at improving operational efficiency and the quality of healthcare through digital twin technology. - FY2025-H1AdvancedAnnual report
「アルフレッサ also introduced products provided by セールスフォース・ジャパン (head office: Chiyoda-ku, Tokyo) and built the “Vaccine Supply Optimization Platform” (service name: ワクチンぷらっと), which improves convenience for people wishing to be vaccinated and medical institutions and enables vaccine supplies to be matched to demand.」
The Company built a digital technology platform to optimize vaccine supply and implemented specific services to improve convenience in healthcare and coordinate supply and demand. - FY2024-Q2AdvancedAnnual report
「The consolidated subsidiary アルフレッサ ヘルスケア株式会社 (head office: Chiyoda-ku, Tokyo) entered into a capital and business alliance agreement with 株式会社MICIN (head office: Chiyoda-ku, Tokyo) and is working to expand the adoption of the telemedicine service “curon (クロン)” and the cashless payment service for outpatient visits, “クロンスマートパス,” among others. It also aims to develop and roll out medical and healthcare services by leveraging the resources of both companies, thereby improving people’s health and access to healthcare.」
Collaboration with venture companies to address healthcare issues progressed to a capital and business alliance with MICIN and the broader adoption of online medical consultations and cashless payment services. - FY2023AdvancedAnnual report
「In February 2023, アルフレッサ entered into an agreement with アクシスルートホールディングス株式会社 for an additional investment. アクシスルートホールディングス株式会社 owns アクシス, a leading cloud-based electronic medication record company and アルフレッサ's capital alliance partner, and the agreement was aimed at providing new value to diversifying pharmacy operations.」
The initiative to address healthcare issues through collaboration with venture companies progressed to an agreement for an additional investment in a company that owns a cloud-based electronic medication history provider. - FY2023-Q2RestatedAnnual report
「The Group is advancing efforts to address issues in healthcare through alliances with various venture companies developing new healthcare services. In June 2022, consolidated subsidiary アルフレッサ株式会社 (headquartered in Chiyoda-ku, Tokyo) entered into a capital and business alliance agreement with フロンティア・フィールド, which provides “日病モバイル,” a smartphone service exclusively for medical institutions, and is headquartered in Minato-ku, Tokyo.」
The Company continues to promote collaboration with venture companies, including the capital and business alliance with フロンティア・フィールド, to address issues in healthcare. - FY2023-Q1ReframedAnnual report
「The Group is advancing efforts to address issues in healthcare through alliances with various venture companies developing new healthcare services. In June 2022, consolidated subsidiary アルフレッサ株式会社 (headquartered in Chiyoda-ku, Tokyo) entered into a capital and business alliance agreement with フロンティア・フィールド, which provides “日病モバイル,” a smartphone service exclusively for medical institutions, and is headquartered in Minato-ku, Tokyo.」
The scope of the initiative has expanded from its previous focus on robotics to addressing healthcare issues through collaboration with venture companies, including providers of smartphone services for medical institutions. - FY2022-Q3RestatedAnnual report
「As part of its investment in venture companies with a view to expanding its business areas, アルフレッサ entered into a capital and business alliance agreement with ドーナッツロボティクス株式会社, headquartered in Minato-ku, Tokyo, in May 2021 and is pursuing cooperation aimed at addressing social issues in healthcare through the use of robotics and digital technologies.」
The Company continues to apply robotics and digital technology in healthcare, starting with its capital and business alliance with ドーナッツロボティクス. - FY2022-Q2RestatedAnnual report
「As part of its investment in venture companies with a view to expanding its business areas, アルフレッサ entered into a capital and business alliance agreement with ドーナッツロボティクス株式会社, headquartered in Minato-ku, Tokyo, in May 2021 and is pursuing cooperation aimed at addressing social issues in healthcare through the use of robotics and digital technologies.」
The Company continues to apply robotics and digital technology in healthcare, starting with its capital and business alliance with ドーナッツロボティクス. - FY2022-Q1First statedAnnual report
「Following the execution of this capital and business alliance, the parties will jointly establish a working group and pursue collaboration aimed at addressing social issues in healthcare through robotics and digital technology.」
The Company began initiatives to apply robotics and digital technology in healthcare through a joint working group, starting with the capital and business alliance with ドーナッツロボティクス.